MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Case reports of first experiences worldwide with novel continuous oral levodopa dental pump in Parkinson’s Disease Patients

    D. Mcintyre, O. Terwindt, L. Pavelka, G. Schilling, A. Znati, L. Skhiri, M. Gantenbein, E. Heller, A. Heller, J. Kennedy, J. Harmon, C. Kamp, M. Torti, CW. Olanow, R. Krueger (Strassen, Luxembourg)

    Objective: To assess the safety, tolerability, and pharmacokinetics (PK) of a novel continuous levodopa-carbidopa oral pump (LCOP) delivery system in patients with early PD. Background:…
  • 2022 International Congress

    Endocannabinoid Dysfunction in Human Disease: Neuro-Ocular DAGLA-related Syndrome (NODrS), a unique pediatric condition

    J. Friedman, A. Mazumder, D. Ogasawara, R. Abou Jamra, G. Bernard, E. Bertini, L. Burglen, A. Crawford, H. Cope, A. Derksen, L. Dure, E. Gantz, M. Koch-Hogrebe, A. Hurst, S. Mahida, P. Marshall, A. Micalizzi, A. Novelli, H. Peng, *. Rady-Children'S-Institute-For-Genomic-Medicine, D. Rodriguez, S. Robbins, L. Rutledge, R. Scalise, S. Schließke, V. Shashi, S. Srivastava, I. Thiffault, S. Topol, *. Undiagnosed-Disease-Network, L. Qebibo, D. Wieczorek, B. Cravatt, S. Haricharan, A. Torkamani, M. Bainbridge (San Diego, USA)

    Objective: To define a new pediatric movement disorder and conclusively link the endocannabinoid system to human disease. Background: The endocannabinoid system is a highly conserved…
  • 2022 International Congress

    Metagenomic exploration of the gut microbiome in a sibling-controlled pilot study of children with Tourette Syndrome

    L. Sycuro, O. Coker, H. Ramay, K. Muirhead, T. Pringsheim, R. Cortez, D. Martino (Calgary, Canada)

    Objective: To detect gut microbial signatures of Tourette syndrome (TS) in the first sibling-controlled investigation of this condition. Background: The contribution of gut microbiome, and…
  • 2022 International Congress

    CLINICAL AND GENEOLOGICAL FEATURES OF PARKINSON’S DISEASE

    S. Kuranbaeva, S. Kalandarova, A. Umarov, G. Goyibova (Tashkent, Uzbekistan)

    Objective: The initial purpose of the work is to study the clinical and genealogical features of Parkinson's disease. Background: Currently, clinical genetics has a number…
  • 2022 International Congress

    DUtch PARkinson Cohort (DUPARC): Contrast Sensitivity and Retinal Changes in Early Parkinson’s Disease Patients

    C. Gillen, S. Zee, N. Jansonius, T. van Laar (Groningen, Netherlands)

    Objective: To identify and characterize the correlation between static contrast sensitivity (SCS), dynamic contrast sensitivity (DCS), and thickness of the internal plexiform layer (IPL) in…
  • 2022 International Congress

    Long-term safety of continuous levodopa/carbidopa infusion with ND0612: Data from patients who continued past one year in the BeyoND study

    S. Isaacson, N. Giladi, F. Stocchi, L. Salin, N. Vostokova, W. Poewe (Boca Raton, USA)

    Objective: To report long-term safety and tolerability data from the ongoing BeyoND study (NCT02726386) for patients who continued treatment past the one-year primary endpoint. Background:…
  • 2022 International Congress

    Dopamine-independent cortical disinhibition in Parkinson’s disease

    C. Ammann, M. Dileone, C. Pagge, D. Mata-Marín, M. Matarrazzo, M. Monje, A. Sánchez-Ferro, B. Fernández-Rodríguez, C. Gasca-Salas, J. Máñez-Miró, R. Martínez-Fernández, L. Vela, F. Alonso-Frech, A. Oliviero, JA. Obeso, G. Foffani (Móstoles, Spain)

    Objective: To test the hypothesis that cortical disinhibition in Parkinson's disease is a dopamine-independent process. Background: Motor cortex alterations in Parkinson's disease are classically considered…
  • 2022 International Congress

    Cortical and cerebellar excitability in essential tremor

    C. Ammann, C. Pagge, JA. Pineda-Pardo, M. Del álamo, R. Martínez-Fernández, A. Oliviero, JA. Obeso, G. Foffani (Móstoles, Spain)

    Objective: To investigate the functional state of motor cortex excitability and the involvement of the cerebello-thalamo-cortical pathway using transcranial magnetic stimulation (TMS) in patients with…
  • 2022 International Congress

    Delayed post-stroke parkinsonism: description of two cases and possible mechanism

    T. Friedeman- Korn, M. Bauer, M. Abu Snineh, C. Weill, D. Arkadir (Jerusalem, Israel)

    Objective: To present two patients who developed delayed parkinsonism years after experiencing midbrain strokes and to suggest a possible mechanism for this delayed phenomenon. Background:…
  • 2022 International Congress

    THE EFFECT OF DEEP BRAIN STIMULATION ON LOWER URINARY TRACT SYMPTOMS IN PARKINSON’S DISEASE

    P. Araújo, A. Francisco, R. de Fraga, L. Frizon, M. ávila, I. Filho, L. Pancera, G. Schaidt, J. Goginski, A. Farinazzo (Curitiba, Brazil)

    Objective: To evaluate lower urinary tract symptoms between Parkinson’s Disease (PD) patients with and without deep brain stimulation (DBS). Background: Parkinson's disease (PD) is well…
  • « Previous Page
  • 1
  • …
  • 29
  • 30
  • 31
  • 32
  • 33
  • …
  • 153
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley